• Semaglutide, Pharmaceutical Peptide, CAS No: 910463-68-2
  • Semaglutide, Pharmaceutical Peptide, CAS No: 910463-68-2
  • Semaglutide, Pharmaceutical Peptide, CAS No: 910463-68-2
  • Semaglutide, Pharmaceutical Peptide, CAS No: 910463-68-2

Semaglutide, Pharmaceutical Peptide, CAS No: 910463-68-2

Powder: Yes
Customized: Customized
Certification: GMP, HSE, ISO 9001, USP, BP
Suitable for: Adult
State: Solid
Purity: >98%
Customization:
Gold Member Since 2023

Suppliers with verified business licenses

Trading Company
  • Overview
  • Product Description
  • Detailed Photos
  • Product Parameters
Overview

Basic Info.

Model NO.
HJYY
Assay
98%
appearance
White Powder
Impurity
Not More Than 2%
Solubility
Soluble in Water
Water
≤8.0%
Peptide Content
≥ 85.0%
Transport Package
1g/Al Bag
Specification
98%
Trademark
HD
Origin
China
HS Code
2937190090
Production Capacity
100000g/Month

Product Description

   

Product Description

Semaglutide, a long-acting GLP-1 analogue, is a glucagon-like peptide-1 (GLP-1) receptor agonist. Semaglutide has the potential for type 2 diabetes treatment.

Detailed Photos

Semaglutide, Pharmaceutical Peptide, CAS No: 910463-68-2Semaglutide, Pharmaceutical Peptide, CAS No: 910463-68-2Semaglutide, Pharmaceutical Peptide, CAS No: 910463-68-2

Product Parameters

Product Info

 
Generic name   Semaglutide
Formula   C187H291N45O59
CAS No.   910463-68-2
Molecular Weight    4113.64
EINECS   203-405-2
Appearance   White powder
Storage Condition   2-8ºC

  Application & Efficacy

   Action Somaglutide is a long-acting dosage form developed based on the basic structure of liraglutide, and its effect in the treatment of type 2 diabetes is better.


        

    Send your message to this supplier

    *From:
    *To:
    *Message:

    Enter between 20 to 4,000 characters.

    This is not what you are looking for? Post a Sourcing Request Now

    You Might Also Like

    Gold Member Since 2023

    Suppliers with verified business licenses

    Trading Company
    Number of Employees
    39
    Year of Establishment
    2011-02-10